These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7810357)

  • 21. Internet suicide guidelines: report of a life-threatening poisoning using tobacco extract.
    Schneider S; Diederich N; Appenzeller B; Schartz A; Lorang C; Wennig R
    J Emerg Med; 2010 Jun; 38(5):610-3. PubMed ID: 19272738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex suicide with homemade nicotine patches.
    Lardi C; Vogt S; Pollak S; Thierauf A
    Forensic Sci Int; 2014 Mar; 236():e14-8. PubMed ID: 24439154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal nicotine patches for eosinophilic pustular folliculitis.
    Yoshifuku A; Higashi Y; Matsushita S; Kawai K; Kanekura T
    J Dermatol; 2013 Sep; 40(9):711-4. PubMed ID: 23802575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine-replacement products in smoking cessation: a review.
    Alsagoff F; Lee HP
    Singapore Med J; 1993 Dec; 34(6):505-10. PubMed ID: 8153711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.
    Keller-Stanislawski B; Caspary S; Merz PG; Bonn R; Wolff M; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):417-21. PubMed ID: 8225689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine poisoning due to intravenous injection of cigarette soakage.
    Hagiya K; Mizutani T; Yasuda S; Kawano S
    Hum Exp Toxicol; 2010 May; 29(5):427-9. PubMed ID: 20068013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Smoking cessation with the nicotine patch].
    Batra A; Buchkremer G
    Z Arztl Fortbild (Jena); 1995 Oct; 89(5):505-9. PubMed ID: 8578778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin tolerability of transdermal patches.
    Wohlrab J; Kreft B; Tamke B
    Expert Opin Drug Deliv; 2011 Jul; 8(7):939-48. PubMed ID: 21506903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study.
    Hong D; Conell-Price J; Cheng S; Flood P
    Anesth Analg; 2008 Sep; 107(3):1005-10. PubMed ID: 18713921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients.
    Salín-Pascual RJ; Basañez-Villa E
    Rev Invest Clin; 2003; 55(6):650-4. PubMed ID: 15011734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal nicotine suppresses cutaneous inflammation.
    Mills CM; Hill SA; Marks R
    Arch Dermatol; 1997 Jul; 133(7):823-5. PubMed ID: 9236519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug poisoning involving nicotine and tramadol.
    Solarino B; Riesselmann B; Buschmann CT; Tsokos M
    Forensic Sci Int; 2010 Jan; 194(1-3):e17-9. PubMed ID: 19850423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder.
    Van Schalkwyk GI; Lewis AS; Qayyum Z; Koslosky K; Picciotto MR; Volkmar FR
    J Autism Dev Disord; 2015 Sep; 45(9):3061-6. PubMed ID: 25982311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
    Wasley MA; McNagny SE; Phillips VL; Ahluwalia JS
    Prev Med; 1997; 26(2):264-70. PubMed ID: 9085397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP; Ziedonis DM; Feingold A; Pepper WT; Satterburg CA; Winkel J; Rounsaville BJ; Kosten TR
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal nicotine as maintenance therapy for ulcerative colitis.
    Thomas GA; Rhodes J; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    N Engl J Med; 1995 Apr; 332(15):988-92. PubMed ID: 7885427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal nicotine replacement and smoking cessation.
    McKenna JP; Cox JL
    Am Fam Physician; 1992 Jun; 45(6):2595-602. PubMed ID: 1595510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients.
    Martin PD; Robinson GM
    N Z Med J; 1995 Jan; 108(992):6-8. PubMed ID: 7862363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.